209 Items, 11 Pages <<Prev 2 3 4 5 6 7 8 9 10 11 Next>> All
No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
---|---|---|---|---|---|---|
101 | IgE | IgE | Diseases | Clinical characteristics | Reference | 1 |
102 | IGF-I | IGF | Biochemical examination | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 2 |
103 | IGF-I/IGFBP-3 | IGF | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
104 | IGF-I:IGFBP-3 ratio | IGF | Biochemical examination | Clinical characteristics | Protective factor No statistical significance factor | 1 |
105 | IGF-II | IGF | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
106 | IGFBP-2 | IGF | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
107 | IGFBP-3 | IGF | Biochemical examination | Clinical characteristics | No statistical significance factor | 2 |
108 | Indication of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
109 | Infertility | Infertility | Diseases | Clinical characteristics | Risk factor | 1 |
110 | Insulin | Antidiabetic | Drug | Clinical characteristics | No statistical significance factor | 1 |
111 | Insulin treatment | Diabetes | Diseases | Clinical characteristics | No statistical significance factor | 1 |
112 | Isovalerate | Metabolic factors | Biochemical examination | Clinical characteristics | Risk factor | 1 |
113 | IVP | Ionising radiation | Accessory examination | Clinical characteristics | No statistical significance factor | 1 |
114 | Ketoprofen | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
115 | Length of right upper arm | Length of right upper arm | Biochemical examination | Clinical characteristics | Protective factor No statistical significance factor | 1 |
116 | Leptin | Leptin | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
117 | Lifetime no. STDs | STD | Diseases | Clinical characteristics | Risk factor | 1 |
118 | linoleate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
119 | linolenate [alpha or gamma | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
120 | LogPASE score | LogPASE score | Biochemical examination | Clinical characteristics | Protective factor | 1 |